Hasil Pencarian - Jungsil Ro
- Menampilkan 1 - 8 hasil dari 8
-
1
-
2
-
3
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer:... oleh Johannes Ettl, Seock-Ah Im, Jungsil Ro, Norikazu Masuda, Marco Colleoni, Patrick Schnell, Eustratios Bananis, Dongrui R. Lu, Massimo Cristofanilli, Hope S. Rugo, Richard S. Finn
Diterbitkan 2020-03-01
Artikel -
4
Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women. oleh Han-Sung Kang, Sei Hyun Ahn, Siddhartha Kumar Mishra, Kyeong-Man Hong, Eun Sook Lee, Kyung Hwan Shin, Jungsil Ro, Keun Seok Lee, Mi Kyung Kim
Diterbitkan 2014-01-01
Artikel -
5
PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Recepto... oleh Hiroji Iwata, Seock-Ah Im, Norikazu Masuda, Young-Hyuck Im, Kenichi Inoue, Yoshiaki Rai, Rikiya Nakamura, Jee Hyun Kim, Justin T. Hoffman, Ke Zhang, Carla Giorgetti, Shrividya Iyer, Patrick T. Schnell, Cynthia Huang Bartlett, Jungsil Ro
Diterbitkan 2017-08-01
Artikel -
6
Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer. oleh Sae-Won Han, Yongjun Cha, Agnes Paquet, Weidong Huang, Jodi Weidler, Yolanda Lie, Thomas Sherwood, Michael Bates, Mojgan Haddad, In Hae Park, Do-Youn Oh, Keun Seok Lee, Seock-Ah Im, Yung-Jue Bang, Jungsil Ro, Tae-You Kim
Diterbitkan 2012-01-01
Artikel -
7
Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer. oleh Han-Seong Kim, Jae-Soo Koh, Yong-Bock Choi, Jungsil Ro, Hyun-Kyoung Kim, Mi-Kyung Kim, Byung-Ho Nam, Kyung-Tae Kim, Vishal Chandra, Hye-Sil Seol, Woo-Chul Noh, Eun-Kyu Kim, Joobae Park, Chang-Dae Bae, Kyeong-Man Hong
Diterbitkan 2014-01-01
Artikel -
8
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer. oleh Sung Hoon Sim, Chang-Dae Bae, Youngmi Kwon, Hai-Li Hwang, Shiv Poojan, Hye-In Hong, Kyungtae Kim, Seo-Hee Kang, Han-Seong Kim, Tae-Hyun Um, In Hae Park, Keun Seok Lee, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Mi-Kyung Kim, Kyeong-Man Hong, Jungsil Ro
Diterbitkan 2017-01-01
Artikel